Posted by Iansf on May 19, 2006, at 16:52:06
In reply to Re: Emsam: aabag, posted by ttee on May 18, 2006, at 9:03:01
> Since Emsam is never going to be a 1st or 2nd line med choice, it is never going to make big bucks for the drug company. For the majority with its only FDA approved indication of Depression, Emsam is going to be reserved for those that have already spent thousands on other "safer" meds first.>
From the initial responses I've read about, I think Emsam WOULD have the potential to become a 1st or 2nd choice. Both the side effect and success profiles appear to be much better than with most antidepressants. But the high cost is going to make it all but impossible for Emsam to gain widespread use. It looks to me more like a case of a drug company finding a way to make a lot of money off a new product while making sure it doesn't cut deeply into the sales of its existing products.
poster:Iansf
thread:642628
URL: http://www.dr-bob.org/babble/20060515/msgs/645998.html